Trupanion (NASDAQ:TRUP) Stock Price Target Cut by Cantor Fitzgerald

Trupanion (NASDAQ:TRUP – Get Free Report) had its price target reduced by analysts at Cantor Fitzgerald from $34.00 to $30.00 in a report issued on Wednesday, MarketBeat Ratings reports. The firm presently has a “neutral” rating on the financial services provider’s stock. Cantor Fitzgerald’s target price points to a potential upside of 16.19% from the stock’s previous close.

Several other equities research analysts have also weighed in on TRUP. Piper Sandler lowered shares of Trupanion from an “overweight” rating to a “neutral” rating and cut their target price for the stock from $45.00 to $32.00 in a report on Wednesday, August 26th. Stifel Nicolaus boosted their price target on shares of Trupanion from $28.00 to $29.00 and gave the company a “hold” rating in a report on Thursday, August 20th. Weiss Ratings raised shares of Trupanion from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, September 29th. Atlantic Securities set a $42.00 price objective on shares of Trupanion in a research report on Wednesday, July 15th. Finally, Zacks Research downgraded Trupanion from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 24th. One research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $38.40.

Get Our Latest Analysis on Trupanion

Trupanion Stock Performance

TRUP stock opened at $25.82 on Wednesday. Trupanion has a twelve month low of $21.16 and a twelve month high of $46.98. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.24. The company has a market cap of $1.13 billion, a P/E ratio of 48.72, a price-to-earnings-growth ratio of 1.70 and a beta of 1.44. The business’s fifty day moving average is $26.89 and its 200-day moving average is $25.50.

Trupanion (NASDAQ:TRUP – Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The financial services provider reported $0.16 EPS for the quarter, beating analysts’ consensus estimates of $0.11 by $0.05. Trupanion had a return on equity of 5.96% and a net margin of 1.53%.The business had revenue of $392.93 million during the quarter, compared to the consensus estimate of $389.72 million. During the same quarter in the prior year, the company posted $0.22 earnings per share. The firm’s revenue was up 11.1% on a year-over-year basis. Equities research analysts forecast that Trupanion will post 0.63 EPS for the current year.

Insider Buying and Selling at Trupanion

In other news, CEO Margaret Tooth sold 978 shares of the stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $29.05, for a total value of $28,410.90. Following the completion of the sale, the chief executive officer owned 175,401 shares of the company’s stock, valued at approximately $5,095,399.05. This represents a 0.55% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO John R. Gallagher sold 3,604 shares of the firm’s stock in a transaction on Friday, August 28th. The shares were sold at an average price of $29.70, for a total transaction of $107,038.80. Following the completion of the transaction, the chief operating officer directly owned 33,742 shares of the company’s stock, valued at $1,002,137.40. This represents a 9.65% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 13,046 shares of company stock worth $380,162 over the last ninety days. 5.58% of the stock is currently owned by corporate insiders.

Institutional Trading of Trupanion

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in shares of Trupanion in the 2nd quarter valued at about $134,774,000. Polar Capital Holdings Plc increased its position in Trupanion by 13.5% during the fourth quarter. Polar Capital Holdings Plc now owns 1,475,000 shares of the financial services provider’s stock worth $55,121,000 after buying an additional 175,000 shares during the last quarter. Greenlea Lane Capital Management LLC increased its position in Trupanion by 1.6% during the fourth quarter. Greenlea Lane Capital Management LLC now owns 776,490 shares of the financial services provider’s stock worth $29,017,000 after buying an additional 12,395 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in Trupanion by 15.7% in the first quarter. Dimensional Fund Advisors LP now owns 702,086 shares of the financial services provider’s stock valued at $17,981,000 after buying an additional 95,064 shares during the period. Finally, Bank of America Corp DE bought a new stake in Trupanion in the second quarter valued at approximately $14,262,000.

About Trupanion

(Get Free Report)

Trupanion, Inc is a pet insurance company that provides medical insurance for cats and dogs. Its coverage is designed to help pet owners manage eligible veterinary expenses, including treatment for accidents, illnesses and other covered medical conditions.

The company offers subscription-based insurance plans primarily through direct-to-consumer channels and partnerships with veterinary practices. Trupanion also provides tools intended to streamline claims processing and enable participating veterinarians to receive payments directly, reducing the need for pet owners to pay eligible costs upfront and seek reimbursement.

Founded in 2000, Trupanion is headquartered in Seattle, Washington.

Recommended Stories

Analyst Recommendations for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.